# Aberrant Gene Expression Prostate Carcinoma

> **NCT00868803** · — · ACTIVE_NOT_RECRUITING · sponsor: **Lahey Clinic** · enrollment: 5000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00868803
- **Lead sponsor:** Lahey Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 1995-04
- **Primary completion:** 2030-04
- **Final completion:** 2030-04
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868803, "Aberrant Gene Expression Prostate Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00868803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*